Stocktoria
Embecta Corp. EMBC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-03-21
Embecta Corp. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.1B | $1.1B | $1.2B |
| Gross profit | $676.8M | $735.2M | $749.9M | $774.9M | $800.4M |
| R&D expense | $37.3M | $78.8M | $85.2M | $66.9M | $63.3M |
| SG&A expense | $332.0M | $365.1M | $341.3M | $294.8M | $240.3M |
| Operating income | $242.1M | $166.8M | $221.5M | $309.6M | $492.0M |
| Income tax | $40.9M | -$34.1M | $35.3M | $33.0M | $80.1M |
| Net income | $95.4M | $78.3M | $70.4M | $223.6M | $414.8M |
| EPS (diluted) | $1.62 | $1.34 | $1.22 | $3.89 | $7.28 |
| Operating cash flow | $191.7M | $35.7M | $67.7M | $412.2M | $456.3M |
| Free cash flow | $182.4M | $19.9M | $41.2M | $388.6M | $419.5M |
| Cash & equivalents | $225.5M | $267.5M | $326.3M | $330.9M | $0 |
| Inventory | $178.6M | $171.5M | $152.1M | $122.8M | $118.0M |
| Total assets | $1.1B | $1.3B | $1.2B | $1.1B | $788.0M |
| Shareholders' equity | -$650.6M | -$738.3M | -$821.7M | -$891.4M | $594.3M |
Source: SEC EDGAR filings · CIK 0001872789 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.